When Kenneth Raymond was diagnosed with Charcot-Marie-Tooth (CMT) disease subtype 1A more than 20 years ago, there was little…
Hawken Miller
Hawken graduated from the University of Southern California (USC) in 2019. Before joining BioNews, he wrote for the Washington Post’s video game and esports section, Launcher, where he still contributes as a freelancer. Hawken is also a columnist for BioNews, focusing on his experience with Duchenne muscular dystrophy for Muscular Dystrophy News Today. His work has appeared in Dot Esports, The Orange County Register, KTLA 5, and The Sacramento Bee. He won a Webby for virtual reality journalism at USC.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Hawken Miller
A chance meeting at a conference four years ago led two researchers to join forces and resulted in a…
Nonprofits, scientists, governmental organizations, and the rare disease drug development industry have long cited…
A Russian military plane crash near Tetiana Zamorska’s home in Kyiv, Ukraine, was a sign that it was time for…
The National Organization for Rare Disorders (NORD) has updated its State Report Card to make it more digitally…
It was an unexpected $1 million gift even for Kent and Michele Stahl. Austin Stahl, 28, and sister…
Patient registries are a hot topic of rare disease research and many organizations are taking advantage of this resource by…
Karina Vaile is an accomplished visual artist, but a diagnosis of Charcot-Marie-Tooth (CMT) disease type 1 subtype A 12…
Bionews, the publisher of this website, hosted a virtual panel discussion on Rare Disease Day 2022, taking a deeper…
A rare disease puts an economic burden on the patients, families, and caregivers that it affects, and will no doubt…